Back to funds
View filing
BIOS Capital Management, LP
hedge fundUpdated 30 days agoManaged by Bios Capital Management, Lp • Latest filing Q2 2026
Portfolio value
$41.7M
Q2 2026
Filings
7
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 7 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2024 | $95.9M |
| Q1 2025 | $79.2M |
| Q2 2025 | $72.6M |
| Q3 2025 | $88.9M |
| Q4 2025 | $82.6M |
| Q1 2026 | $52.9M |
| Q2 2026 | $41.7M |
Top holdings
9 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | I IRD OPUS GENETICS INC | $15.1M | 3.68M | 36.33% | — |
| 2 | ? N/A ACTUATE THERAPEUTICS INC | $13.1M | 8.59M | 31.55% | — |
| 3 | C CGTX COGNITION THERAPEUTICS INC | $6.3M | 5.50M | 15.18% | — |
| 4 | ? N/A ACTUATE THERAPEUTICS INC | $2.2M | 1.46M | 5.35% | — |
| 5 | ? N/A REIN THERAPEUTICS INC | $1.8M | 1.76M | 4.39% | — |
| 6 | ? N/A REIN THERAPEUTICS INC | $1.3M | 1.22M | 3.05% | — |
| 7 | L LTRN LANTERN PHARMA INC | $1M | 249.4K | 2.50% | — |
| 8 | C CGTX COGNITION THERAPEUTICS INC | $575K | 500.1K | 1.38% | — |
| 9 | ? N/A IN8BIO INC | $114K | 81.0K | 0.27% | — |